Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Interventional Cardiology Market by Type (Cardiology catheters, Guidewires, Balloon catheters, Coronary stents, Fractional flow reserve, Intravascular ultrasound), By Application (Application I, Application II) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Interventional Cardiology Market by Type (Cardiology catheters, Guidewires, Balloon catheters, Coronary stents, Fractional flow reserve, Intravascular ultrasound), By Application (Application I, Application II) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 133553 3300 Chemical & Material 377 241 Pages 4.8 (40)
                                          

The global interventional cardiology market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients with cardiovascular diseases and the rising demand for minimally invasive procedures. The global interventional cardiology market by type includes cardiology catheters, guidewires, balloon catheters, coronary stents and fractional flow reserve devices. Cardiology catheters are used in diagnostic procedures such as angiography and cardiac mapping; guidewires are used in diagnostic procedures such as angiography; balloon catheters are used in diagnostic procedures such as angioplasty; coronary stents are used in treatment of blocked arteries; and fractional flow reserve devices are used for diagnosis of narrowed arteries. The application segment includes application I (diagnostic) and application II (treatment). Application I includes cardiac mapping, cardiac angiography, cardiac ablation therapy and other applications while application II includes percutaneous coronary intervention (PCI), percutaneous transluminal coronary angioplasty (PTCA) or ballooning procedure, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) or mitral valve repair procedure). North America is expected to dominate the global interventional cardiology market due to high prevalence rates for cardiovascular diseases among its population.

  1. The aging population is a major factor in the growth of the Interventional Cardiology market.
  2. The increasing prevalence of cardiovascular diseases is also a major factor in the growth of the Interventional Cardiology market.
  3. Increasing awareness about heart disease and its prevention is also a major factor in the growth of the Interventional Cardiology market.
  4. Increasing number of hospitals and healthcare facilities are investing in new technologies to improve patient care, which will lead to an increase in demand for interventional cardiologists, which will lead to an increase in demand for interventional cardiology services, which will lead to an increase in demand for interventional cardiology equipment, which will lead to an increase in demand for interventional cardiology consumables, all leading to increased revenue opportunities for companies operating within this industry over time as they continue investing into research and development activities that are focused on improving patient outcomes through innovative technologies that can be used during cardiac interventions such as angioplasty or stenting procedures or other procedures such as coronary artery bypass grafting (CABG) surgery or valve replacement surgery (VRS).
  5. Technological advancements have led to improved diagnostic capabilities and more accurate diagnosis rates with less invasive procedures than ever before; this has led many patients who would have otherwise been diagnosed with heart disease at later stages when it becomes more difficult and expensive to treat due to complications arising from advanced stages of heart disease being able to be diagnosed earlier on when it's easier and cheaper treatable by means of minimally invasive procedures such as angioplasty or stenting procedures or other procedures such as coronary artery bypass grafting (CABG) surgery or valve replacement surgery (VRS).

Industry Growth Insights published a new data on “Interventional Cardiology Market”. The research report is titled “Interventional Cardiology Market research by Types (Cardiology catheters, Guidewires, Balloon catheters, Coronary stents, Fractional flow reserve, Intravascular ultrasound), By Applications (Application I, Application II), By Players/Companies Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE & Co. KG, Bard Peripheral Vascular?Inc, TERUMO CORPORATION, KANEKA, OrbusNeich Medical, BV, Cordis Cashel, Kimal Plc, Volcano Corporation, Siemens Medical Solutions USA, Inc, Lepu, MicroPort ”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Interventional Cardiology Market Research Report

By Type

Cardiology catheters, Guidewires, Balloon catheters, Coronary stents, Fractional flow reserve, Intravascular ultrasound

By Application

Application I, Application II

By Companies

Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE & Co. KG, Bard Peripheral Vascular?Inc, TERUMO CORPORATION, KANEKA, OrbusNeich Medical, BV, Cordis Cashel, Kimal Plc, Volcano Corporation, Siemens Medical Solutions USA, Inc, Lepu, MicroPort 

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

241

Number of Tables & Figures

169

Customization Available

Yes, the report can be customized as per your need.


Global Interventional Cardiology Industry Outlook


Global Interventional Cardiology Market Report Segments:

The global Interventional Cardiology market is segmented on the basis of:

Types

Cardiology catheters, Guidewires, Balloon catheters, Coronary stents, Fractional flow reserve, Intravascular ultrasound

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Application I, Application II

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Medtronic, Inc.
  2. Boston Scientific Corporation
  3. Abbott Vascular
  4. MINVASYS S.A.S.
  5. BIOTRONIK SE & Co. KG
  6. Bard Peripheral Vascular?Inc
  7. TERUMO CORPORATION
  8. KANEKA
  9. OrbusNeich Medical, BV
  10. Cordis Cashel
  11. Kimal Plc
  12. Volcano Corporation
  13. Siemens Medical Solutions USA, Inc
  14. Lepu
  15. MicroPort 

Global Interventional Cardiology Market Overview


Highlights of The Interventional Cardiology Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Cardiology catheters
    2. Guidewires
    3. Balloon catheters
    4. Coronary stents
    5. Fractional flow reserve
    6. Intravascular ultrasound
  1. By Application:

    1. Application I
    2. Application II
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Interventional Cardiology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Interventional Cardiology Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Interventional cardiology is a type of cardiovascular medicine that uses medical devices and techniques to diagnose and treat heart disease. Interventional cardiologists may perform procedures such as angioplasty, stenting, or bypass surgery.

Some of the major companies in the interventional cardiology market are Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE & Co. KG, Bard Peripheral Vascular?Inc, TERUMO CORPORATION, KANEKA, OrbusNeich Medical, BV, Cordis Cashel, Kimal‚ Plc, Volcano Corporation, Siemens Medical Solutions USA, Inc, Lepu, MicroPort‚ .

The interventional cardiology market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Interventional Cardiology Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Interventional Cardiology Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Interventional Cardiology Market - Supply Chain
   4.5. Global Interventional Cardiology Market Forecast
      4.5.1. Interventional Cardiology Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Interventional Cardiology Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Interventional Cardiology Market Absolute $ Opportunity

5. Global Interventional Cardiology Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Interventional Cardiology Market Size and Volume Forecast by Type
      5.3.1. Cardiology catheters
      5.3.2. Guidewires
      5.3.3. Balloon catheters
      5.3.4. Coronary stents
      5.3.5. Fractional flow reserve
      5.3.6. Intravascular ultrasound
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Interventional Cardiology Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Interventional Cardiology Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Interventional Cardiology Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Interventional Cardiology Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Interventional Cardiology Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Interventional Cardiology Demand Share Forecast, 2019-2029

9. North America Interventional Cardiology Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Interventional Cardiology Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Interventional Cardiology Market Size and Volume Forecast by Type
      9.7.1. Cardiology catheters
      9.7.2. Guidewires
      9.7.3. Balloon catheters
      9.7.4. Coronary stents
      9.7.5. Fractional flow reserve
      9.7.6. Intravascular ultrasound
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Interventional Cardiology Demand Share Forecast, 2019-2029

10. Latin America Interventional Cardiology Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Interventional Cardiology Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Interventional Cardiology Market Size and Volume Forecast by Type
      10.7.1. Cardiology catheters
      10.7.2. Guidewires
      10.7.3. Balloon catheters
      10.7.4. Coronary stents
      10.7.5. Fractional flow reserve
      10.7.6. Intravascular ultrasound
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Interventional Cardiology Demand Share Forecast, 2019-2029

11. Europe Interventional Cardiology Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Interventional Cardiology Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Interventional Cardiology Market Size and Volume Forecast by Type
      11.7.1. Cardiology catheters
      11.7.2. Guidewires
      11.7.3. Balloon catheters
      11.7.4. Coronary stents
      11.7.5. Fractional flow reserve
      11.7.6. Intravascular ultrasound
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Interventional Cardiology Demand Share, 2019-2029

12. Asia Pacific Interventional Cardiology Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Interventional Cardiology Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Interventional Cardiology Market Size and Volume Forecast by Type
      12.7.1. Cardiology catheters
      12.7.2. Guidewires
      12.7.3. Balloon catheters
      12.7.4. Coronary stents
      12.7.5. Fractional flow reserve
      12.7.6. Intravascular ultrasound
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Interventional Cardiology Demand Share, 2019-2029

13. Middle East & Africa Interventional Cardiology Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Interventional Cardiology Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Interventional Cardiology Market Size and Volume Forecast by ApplicationIII
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Interventional Cardiology Market Size and Volume Forecast by Type
      13.7.1. Cardiology catheters
      13.7.2. Guidewires
      13.7.3. Balloon catheters
      13.7.4. Coronary stents
      13.7.5. Fractional flow reserve
      13.7.6. Intravascular ultrasound
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Interventional Cardiology Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Interventional Cardiology Market: Market Share Analysis
   14.2. Interventional Cardiology Distributors and Customers
   14.3. Interventional Cardiology Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Medtronic, Inc.
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Boston Scientific Corporation
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Abbott Vascular
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. MINVASYS S.A.S.
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. BIOTRONIK SE & Co. KG
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Bard Peripheral Vascular?Inc
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. TERUMO CORPORATION
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. KANEKA
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. OrbusNeich Medical, BV
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Cordis Cashel
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Kimal Plc
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Volcano Corporation
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Siemens Medical Solutions USA, Inc
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Lepu
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. MicroPort 
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us